Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac Remodeling in Chronic Kidney Disease
Nadine Kaesler, Anne Babler, Jürgen Floege, et al.
Toxins (2020) Vol. 12, Iss. 3, pp. 161-161
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Chronic Kidney Disease as a Comorbidity in Heart Failure
Magdalena Szlagor, Jill Dybiec, Ewelina Młynarska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2988-2988
Open Access | Times Cited: 52
Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
Jonathan P. Law, Luke Pickup, Davor Pavlović, et al.
Journal of Human Hypertension (2022) Vol. 37, Iss. 1, pp. 1-19
Open Access | Times Cited: 50
Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
Husam M. Salah, Subodh Verma, Carlos G. Santos‐Gallego, et al.
Journal of Cardiovascular Translational Research (2022) Vol. 15, Iss. 5, pp. 944-956
Closed Access | Times Cited: 40
Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench
Xin Chen, Carl‐Friedrich Hocher, Linghong Shen, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C661-C681
Closed Access | Times Cited: 30
Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
Hyoungnae Kim, Mi Ra Yu, Haekyung Lee, et al.
Aging Cell (2021) Vol. 20, Iss. 2
Open Access | Times Cited: 48
Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy
Kazutoshi Yamaguchi, Maimaiti Yisireyili, Sumie Goto, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 4, pp. 365-377
Closed Access | Times Cited: 31
Reduced Estimated GFR and Cardiac Remodeling: A Population-Based Autopsy Study
Kensuke Izumaru, Jun Hata, Toshiaki Nakano, et al.
American Journal of Kidney Diseases (2019) Vol. 74, Iss. 3, pp. 373-381
Open Access | Times Cited: 44
Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering – Do patient characteristics warrant precision engineering?
B. Kort, Suzanne E. Koch, Tamar B. Wissing, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113960-113960
Open Access | Times Cited: 37
Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
Anastasia V. Poznyak, Nikolay K. Sadykhov, Andrey G. Kartuesov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2094-2094
Open Access | Times Cited: 23
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure
Alberto Ortíz, Juan F. Navarro‐González, Julio Núñez, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 5, pp. 865-872
Open Access | Times Cited: 30
Defining the predictors for post renal transplant left ventricular dysfunction in end‐stage renal disease patients
Mahboobeh Sheikhani, Hoorak Poorzand, Mahnaz Ahmadi, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access
Beyond the heart: Understanding the systemic impact of cardiomyopathies
Omar Elsaka
Current Medicine Research and Practice (2025) Vol. 15, Iss. 1, pp. 25-31
Open Access
Differential Myocardial Responses in Male and Female Rats with Uremic Cardiomyopathy
Beáta Bódi, R. Vago, László Nagy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2259-2259
Open Access
Differential Impact of Chronic Kidney Disease Stages on the Survival Benefit of Percutaneous Coronary Intervention: A Large Real-world Cohort Study
Xiaozhao Lu, Jin Liu, Jingru Deng, et al.
Angiology (2025)
Closed Access
Gene–Lifestyle Interactions in Renal Dysfunction: Polygenic Risk Modulation via Plant-Based Diets, Coffee Intake, and Bioactive Compound Interactions
Meiling Liu, Dasol Kim, Sunmin Park
Nutrients (2025) Vol. 17, Iss. 5, pp. 916-916
Open Access
Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis
Gregorio Romero‐González, Arantxa González, Begoña López, et al.
Nephrology Dialysis Transplantation (2020) Vol. 37, Iss. 5, pp. 817-824
Closed Access | Times Cited: 28
Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats
Márta Sárközy, Simon Watzinger, Zsuzsanna Z. A. Kovács, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 9, pp. 1160-1176
Open Access | Times Cited: 9
Nomogram‐based risk assessment model for left ventricular hypertrophy in patients with essential hypertension: Incorporating clinical characteristics and biomarkers
Chuang‐chang Wang, Likeng Liang, Sheng‐ming Luo, et al.
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 4, pp. 363-373
Open Access | Times Cited: 3
A nomogram for predicting the risk of heart failure with preserved ejection fraction
Hua Li, Rong Zhang, Ruichang Chen, et al.
International Journal of Cardiology (2024) Vol. 407, pp. 131973-131973
Closed Access | Times Cited: 3
Sacubitril-Valsartan in Patients Requiring Hemodialysis
Dustin Le, Morgan E. Grams, Josef Coresh, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2429237-e2429237
Open Access | Times Cited: 3
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy
Alessandro Bellis, Giuseppe Di Gioia, Ciro Mauro, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2968-2968
Open Access | Times Cited: 22
A systematic review and meta-analysis of murine models of uremic cardiomyopathy
Josefin Soppert, Janina Frisch, Julia J. Wirth, et al.
Kidney International (2021) Vol. 101, Iss. 2, pp. 256-273
Open Access | Times Cited: 21
Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help?
Maria-Ruxandra Cepoi, Ștefania-Teodora Duca, Adriana Chetran, et al.
Life (2023) Vol. 14, Iss. 1, pp. 34-34
Open Access | Times Cited: 8
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy
Zsuzsanna Z. A. Kovács, Gergő Szűcs, Marah Freiwan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females
Márta Sárközy, Fanni Márványkövi, Gergő Szűcs, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top